( AMEX:PFNX )

News from Pfenex Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 09, 2017, 18:15 ET Pfenex Inc. to Present at the Jefferies 2017 London Healthcare Conference

Pfenex Inc. (NYSE AMERICAN: PFNX), announced today that it will be presenting at the Jefferies 2017 London Healthcare Conference on Wednesday,...


Nov 09, 2017, 16:05 ET Pfenex Reports Third Quarter 2017 Results, Interim PK data from PF708 Study, Completion of Process Development Milestone on Jazz Program and Provides Business Update

Pfenex Inc. (NYSE American: PFNX) is a clinical-stage biotechnology company developing complex therapeutic proteins. Using the patented Pfenex...


Oct 30, 2017, 16:05 ET Pfenex to Report Third Quarter 2017 Results and Provide Business Update on Thursday, November 9, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that its third quarter 2017 financial results will be released on Thursday, November 9, 2017, after...


Sep 19, 2017, 07:00 ET Pfenex To Present at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the Cantor Fitzgerald Global Healthcare Conference on September 27th,...


Sep 07, 2017, 17:45 ET Pfenex Announces Management Changes

Pfenex Inc. (NYSE MKT: PFNX), today announced that Dr. Paul Wagner, Chief Financial Officer, is leaving the Company effective October 13, 2017 to...


Sep 01, 2017, 07:00 ET Pfenex Reports New Employment Inducement Award Under NYSE MKT Listing Rules

Pfenex Inc. (NYSE MKT: PFNX) ("Pfenex" or the "Company"), a clinical-stage biotechnology company engaged in the development of biosimilar...


Aug 29, 2017, 06:00 ET Pfenex To Present at the 19th Annual Rodman and Renshaw Global Investment Conference on September 12th, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the 19th Annual Rodman and Renshaw Global Investment Conference on...


Aug 23, 2017, 08:00 ET Pfenex To Present at the 6th Annual Liolios Gateway Conference on September 6th, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that it will be presenting at the 6th Annual Liolios Gateway Conference on September 6th, 2017 at...


Aug 09, 2017, 16:05 ET Pfenex Reports Second Quarter 2017 Results and Provides Business Update

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...


Aug 03, 2017, 06:00 ET Pfenex Names Eef Schimmelpennink Chief Executive Officer

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...


Jul 25, 2017, 17:00 ET Pfenex To Report Second Quarter 2017 Results and Provide Business Update on Wednesday, August 9, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that its second quarter 2017 financial results will be released on Wednesday August 9, 2017, after the...


Jun 08, 2017, 08:00 ET Pfenex to Present at the 2017 JMP Healthcare Conference

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...


May 08, 2017, 16:05 ET Pfenex Reports First Quarter 2017 Results and Provides Business Update

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...


Apr 03, 2017, 10:00 ET Sigurdur (Siggi) Olafsson And Jason Grenfell-Gardner Nominated To Serve On Board Of Directors

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...


Mar 31, 2017, 16:05 ET William R. Rohn Announces Plans To Retire As Chairman And Board Member

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...


Mar 15, 2017, 16:05 ET Pfenex Reports Fourth Quarter and Full Year 2016 Results and Provides Business Update

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...


Mar 01, 2017, 08:00 ET Pfenex To Report Fourth Quarter and Full Year 2016 Results and Provide Business Update on Wednesday, March 15, 2017

Pfenex Inc. (NYSE MKT: PFNX) announced today that its fourth quarter and full year 2016 financial results will be released on Wednesday, March 15,...


Feb 10, 2017, 06:00 ET Pfenex Inc. to Participate in Panel Discussion at 2017 BIO CEO & Investor Conference

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high-value...


Jan 24, 2017, 08:00 ET Pfenex Announces Leadership Transition

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...


Dec 01, 2016, 17:00 ET Pfenex Reports New Employment Inducement Award Under NYSE MKT Listing Rules

Pfenex Inc. (NYSE MKT: PFNX) ("Pfenex" or the "Company"), a clinical-stage biotechnology company engaged in the development of biosimilar...


Nov 09, 2016, 16:05 ET Pfenex Reports Third Quarter 2016 Results and Provides Business Update

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...


Oct 26, 2016, 18:30 ET Pfenex To Report Third Quarter 2016 Results and Provide Business Update on Wednesday, November 9, 2016

Pfenex Inc. (NYSE MKT: PFNX) announced today that its third quarter 2016 financial results will be released on Wednesday, November 9, 2016, after...


Oct 19, 2016, 18:00 ET Pfenex Inc. Announces Formation of Scientific Advisory Board

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics and high-value, difficult to manufacture...


Oct 03, 2016, 18:00 ET Pfenex Reports New Employment Inducement Award Under NYSE MKT Listing Rules

 Pfenex Inc. (NYSE MKT: PFNX) ("Pfenex" or the "Company"), a clinical-stage biotechnology company engaged in the development of biosimilar...


Aug 08, 2016, 07:30 ET Pfenex Reports Second Quarter 2016 Results and Provides Business Update

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high...